Treatment of malignancy with unmodified antibody.
Badger
C C
CC
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Wash.
Anasetti
C
C
Davis
J
J
Bernstein
I D
ID
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000502:physiology / Q000627:therapeutic use*; D000918:Antibody Specificity; D000920:Antibody-Dependent Cell Cytotoxicity; D000941:Antigens / Q000502:physiology; D004334:Drug Administration Schedule; D006801:Humans; D007132:Immunoglobulin Isotypes / Q000502:physiology; D009369:Neoplasms / Q000628:therapy*
D000911:Antibodies, Monoclonal; D000941:Antigens; D007132:Immunoglobulin Isotypes